Engage in Biological Technology

BIO Ventures for Global Health Receives $7 Million Grant from Gates Foundation to Engage Biotechnology in the Fight Against Neglected Diseases of the Developing World

-Funds to support creation of market incentives and facilitate new R&D collaborations- WASHINGTON, Oct. 14 /PRNewswire-USNewswire/ -- BIO Ventures for Global Health (BVGH) today announced that the Bill & Melinda Gates Foundation has expanded its support of the organization, so it can further...

UW professors get grants to engage technology for course delivery

Madison, Wis. -- UW-Madison Civil and Environmental Engineering professor Steve Cramer and Engineering Physics professor Jake Blanchard have both received approximately $40,000 from the John and Jean Berndt Technology-Enhanced Learning Initiative to develop innovative teaching approaches. Cra...

Marketers advised to engage "search economy"

Madison, Wis. - There is both a new World Wide Web and a new, customer-centric world order that businesses and their branding/marketing professionals would be wise to adapt to, according to the leadoff hitters at Brandworks University 2006. This year's conference, which is being held at Mon...

PharmAthene, Inc. Closes on $19.3 Million Private Placement of Convertible Notes and Common Stock Warrants

...009. The Warrants will be exercisable for a period of five years beginning six months after the closing of the private placement. The Company did not engage a placement agent in connection with this transaction. About the Securities The securities that are being sold in the transaction have not ...

Genetically engineered bacteria compute the route

...c biology affords a new opportunity for multidisciplinary undergraduate research training. "We have found synthetic biology to be an excellent way to engage students in research that connects biology and mathematics. Our students learn firsthand the value of crossing traditional disciplinary lines." ...

Schering-Plough Reports Financial Results for 2009 Second Quarter

...pean Commission under the EC Merger Regulation and certain other foreign jurisdictions. (Announced June 25) Reported results from the Phase III engage clinical trial demonstrating that a single injection of corifollitropin alfa, first in the class of sustained follicle stimulants, achieved similar ef...

iSource Networks Partners with inVentiv Health to Develop New Technology Platform for Reaching Healthcare Consumers

...the worlds of healthcare, technology, psychology, and communications providing mass one-on-one communications that better connect and more dynamically engage consumers with trusted resources. For more information, visit www.isourcenetworks.com . ...

Verenium Completes Amendment to 8% Senior Convertible Notes

... Modifications providing Verenium with greater flexibility to engage in certain financing and other strategic transactions, including the ability to incur indebtedness or liens and engage in restructuring transactions involving its 5.50% convertible senior notes;...

Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa

... SGP ) today announced results from the Phase III engage clinical trial demonstrating that a single injecti...rmone (rFSH) given once daily for seven days. The engage data was presented along with data from the Phase ...ions and the length of treatment protocols." engage is the largest double-blind fertility agent trial ...

PROLOR Biotech Awarded Two U.S. Patents for Its Longer-Acting Human Growth Hormone and Longer-Acting Erythropoietin

... CTP technology has been demonstrated by Schering-Plough, which is developing the technology for fertility applications only. Data from its Phase III engage trial demonstrated that women receiving a single injection of the fertility drug FSH-CTP achieved the same pregnancy rates as women receiving seven co...

I Walk Because Program Gives Consumers a Voice

...ed really positive feedback on 'I Walk Because,' and decided to enhance the online user experience in 2009 so that the content and functionality would engage people throughout the year, not just around WalkMS." Walkers can use their personal profiles to showcase their walking gear, playlists, favorite ...

Sigma-Aldrich Introduces New Services Network Complementing Its Life Sciences Product Portfolio

...services from a centralized website location ( www.sigma-aldrich.com/life-science/life-science-services.html ). The Network will allow scientists to engage Sigma-Aldrich resources and certified partners for laboratory services on an as-needed basis, freeing them to concentrate on core research objectives....

Orange County Laser Surgeon Nissan Pilest Tapped as Keynote Speaker at Fraxel & Thermage User Forum Held at Beckman Laser Institute

...leave the office with a reduced circumference in the areas treated. It's quite amazing." The attending physicians were given opportunities to engage in discussion of pros and cons of both nonsurgical means of skin tightening and fractional resurfacing plus fractional skin coagulation which is used ...

China Sky One Medical, Inc. Appoints Pricewaterhouse Coopers to Help Develop a SOX 404 Compliance Program

... internal financial reporting and controls systems after documenting and testing financial reporting and control procedures. "We are pleased to engage PWC for this important undertaking as we strive to ensure that the Company is in full compliance with SOX 404 reporting requirements as we continue to...

WellGen, Inc. Launches Te Ame(TM) Nutritional Supplements With Proven Health Benefits of Proprietary Black Tea Extract

...y. Te Ame(TM) Stress Manager is scientifically formulated to improve the body's response to stress. To purchase Te Ame(TM) products online or to engage in the Te Ame(TM) conversations, please go to www.te-ame.com . About WellGen. WellGen, Inc., based in North Brunswick, N.J., is a life sci...

ASCP Joins ACLU Lawsuit Opposing Gene Patents

... and limits those in the practice of pathology and laboratory medicine from doing what they are educated to do -- provide high quality health care and engage in research that will enhance the practice of medicine and patient care," Dr. McKenna said. The lawsuit states the patents restrict ease of a...

Roche Announces Long-Term Commitment to Tackle Growing Epidemic of Diabetes

...ierstraete. "Traditional diabetes management tends to focus on telling people with diabetes what to do but that, by itself, doesn't necessarily fully engage patients. Our initiative, Behavior Change through Patient Engagement, is all about helping patients take an active role in their diabetes self-care. W...

Dendreon Announces Data Presentations and Webcast at AUA Annual Meeting

...duct candidate for men with advanced prostate cancer representing the first in a new class of active cellular immunotherapies specifically designed to engage the patient's own immune system against cancer. Dendreon announced last week that the IMPACT trial met its primary endpoint of improving overall surv...

Dendreon Announces Data on PROVENGE Potency and Long-Term Immune Responses in Androgen-Dependent Prostate Cancer

... the first product in a new class of active cellular immunotherapies (ACIs). PROVENGE and other ACIs are uniquely designed to use live human cells to engage the patient's own immune system with the goal of eliciting a specific long-lasting response against cancer. In controlled clinical trials, the most co...

China Biologic Products Completes Acquisition of 90% Controlling Interest in Chongqing Dalin Biologic Technologies Co., Ltd.

... Guizhou Province has historically produced the highest volumes of plasma collection in China, due to a higher proportion of its population willing to engage in the collection process. Guizhou Province has a total of 19 plasma collection stations in operation, collecting approximately 1200 tons of plasma su...

APS Healthcare and Thomson Reuters to Manage New York State's Medicaid Clinical Best Practices Review Program

...ico , which serve more than 40 percent of the nation's Medicaid population. APS delivers customized, integrated healthcare solutions that help people engage in behaviors that optimize their health status. By uniting all participants in the healthcare landscape -- individuals, practitioners and payers -- AP...

Executive Coaching Firm Mariposa Leadership, Inc. Hosts Webinar to Help Business Leaders Navigate Tumultuous Economy

...ty - Become an Efficiency Champion Innovation - Create a Think-Tank Mentality Productivity - Be Transparent and Over-Communicate Innovation - engage Employees Through In-The-Moment Coaching To download the special report "Five Keys to Increase Your Organization's Resilience in the Downturn...

Pharmaceutical Institute Launches New Training Series Focused on Managed Markets Excellence

... Introduction to Managed Markets - This course provides team members with the managed markets foundation they need to be able to engage in thoughtful discussions about managed care, including proper terminology, the managed markets buying process, the various channels and stakeholders ...

PROVENGE Significantly Prolongs Survival in Men With Advanced Prostate Cancer in Pivotal Phase 3 IMPACT Study

... in a new class of active cellular immunotherapies specifically designed to engage the patient's own immune system against cancer. Detailed results from .... PROVENGE and other ACIs are uniquely designed to use live human cells to engage the patient's own immune system with the goal of eliciting a specific long-...

Pre-Clinical Data on CEA-specific BiTE Antibody Published in Journal of Immunotherapy Demonstrate Potent Control of Tumor Growth

...t a new therapeutic approach to cancer therapy. Typically antibodies cannot engage T cells because T cells lack the appropriate receptors for binding antibodi...on by T cells. The use of BiTE antibodies that are specifically designed to engage T cells for attacking cancer cells may provide a more effective anti-tumor ...

NovaBay Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2008 Financial Results

...use or contribute to such differences include, but are not limited to: the risk that NovaBay may incur unexpected charges or need to or determined to engage in research and development not previously planned, which will cause NovaBay's cash burn to be greater than it expects; risks and uncertainties relati...

Sigma-Aldrich Enters Exclusive Supply Agreement With Gene Oracle to Leverage Its Unique GeneIOS Gene Synthesis Platform

... Under the terms of the agreement, Sigma-Aldrich will be the exclusive supplier of custom oligonucleotides for Gene Oracle, and the two Companies will engage in co-marketing efforts to promote the GeneIOS system and their expert gene synthesis services ( http://www.sigma.com/oligos ). The GeneIOS s...

Biotechnology Value Fund, L.P. Announces Overwhelming Support to Remove the Board of Directors of Avigen, Inc. at Special Meeting of Stockholders

...o stockholders months ago. We also wish to acknowledge the constructive and bold efforts of MediciNova throughout this process. We encourage Avigen to engage with MediciNova during the liquidation process; we intend to be helpful in this regard." BVF's existing tender offer will terminate because BVF's...

Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2008 Financial Results

...ugh 2010. Furthermore, once we report initial top-line results for our U.S. Phase II cocaine trial, our strengthened balance sheet should allow us to engage potential corporate partners and explore a variety of transactions on terms that may prove to be more favorable to our shareholders. Concurrently, we...

Cells Exhibition Opens at Maryland Science Center

...red with the Liz Lerman Dance Exchange, who interpreted cell behavior through videotaped sequences where dancers interpret the words of scientists and engage visitors in moving their own bodies to explore the microscopic world. Students and faculty from the Maryland Institute College of Art worked with Mary...

Biotechnology Value Fund Urges Stockholders to Remove and Replace Current Board of Avigen, Inc. in an Effort to Protect and Maximize Stockholder Value

...ments to consultants, bankers and lawyers are quickly adding up as well. Given the current economic conditions, we find it irresponsible for Avigen to engage in such behavior that amounts to a slap in the face of all Avigen stockholders. The recent addition of a poison pill by the Board adds further insult ...

US Oncology Named to FORTUNE Magazine's Most Admired Companies List for Third Time

...he programs reduce treatment variability, contain costs and improve patient outcomes Oncology Portal: web portal where oncology physicians can engage in virtual tumor boards, share information, stay current on the latest innovations and gain access to the most up-to-date clinical information and res...

Former President of Sports Cardiology Consultants, LLC Christine Lawless, MD, MBA, ABCL, FACC, FACSM, Named Medical Director of CME Enterprise

...ternal Medicine and Co-Director of Ross Heart Hospital Lipid Clinic. "Placing Dr. Lawless as Medical Director greatly increases opportunities to engage in cardiovascular and sports medicine, ensuring that the CME Enterprise team will continue its growth as a consummate professional education resource ...

ExonHit Therapeutics Invested Strongly in 2008 for Pivotal 2009 Results

...e, the Company will put its first product on the market. Furthermore, assuming successful completion of the EHT 0202 Phase lla study, the Company will engage in out-licensing activities to support further development of this product in Alzheimer's disease. 2008 Consolidated financial results P...

NPSF Issues New Universal Patient Compact During Patient Safety Awareness Week

...ness Week, please visit www.npsf.org . About Patient Safety Awareness Week Held annually, Patient Safety Awareness Week is designed to engage staff, patients, and community by emphasizing the critical need for partnership and participation in the drive for a safer healthcare system. Programs...

ThromboGenics and BioInvent Start Phase II Trial of TB-402, a Novel, Long Acting Anticoagulant for Deep Vein Thrombosis (DVT) Prophylaxis

...f choice to prevent DVT in patients undergoing surgery. Given the size of the market opportunity for TB-402 and the sales reach that will be needed to engage with the potential prescribers of TB-402, it is our intention to seek a partner to undertake the later stage development and commercialisation of this...

EESTECH Inc - Release From SEC Filing

... from the Pink Sheets. The company has, historically, been required to engage the services of a PCAOB Auditor in the United States and Australia at an an...s that, in the interests of sound corporate governance, it will continue to engage a PCAOB registered auditor in Australia to undertake an annual Audit of the...

Accera, Inc. Sponsors Alzheimer's Association's 2009 ICAD Conference

...new and innovative therapies. ICAD 2009 is expected to draw approximately 5,000 researchers, clinicians and neurologists from around the world to engage in a multidisciplinary exchange of ideas. The international sharing of research looks to advance prevention methods, treatments and a cure for AD. ...

Shengtai Pharmaceutical, Inc. Reports Second Quarter Fiscal 2009 Financial Results

...ets, many of our key customers are actively launching new products including higher margin non-PVC soft packaging transfusion products. We continue to engage with our current customers in an effort to increase their purchase volumes, as we seek to better understand their current procurement needs and new pr...

Biotechnology Value Fund, L.P. Requests Avigen Board to Provide Critical Information to Stockholders

...hat it had retained not one but two financial advisers , RBC Capital Markets and Pacific Growth Equities LLC. Why did the Board find it necessary to engage two financial advisers? Will these advisors be paid in the same currency as stockholders or will they, like management, take cash and leave stockhold...